VINTAGE PHARMS
GenericsVINTAGE PHARMS is a generic drug manufacturer focused on Dermatology, Cardiovascular, Neurology.
VINTAGE PHARMS's Key Drugs
VINTAGE PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
VINTAGE PHARMS's Recent FDA Approvals
New NDA/BLA approvals for VINTAGE PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
VINTAGE PHARMS's Therapeutic Areas
VINTAGE PHARMS's approved drugs and pipeline span 3 therapeutic areas, led by Dermatology and Cardiovascular, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
VINTAGE PHARMS's Top Competitors
VINTAGE PHARMS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, PAI HOLDINGS PHARM, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
VINTAGE PHARMS Pipeline Snapshot
Active clinical trials for VINTAGE PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1986-08-01
- Latest
- 2012-01-27
- Applications
- 29